Program Overview
Speakers will present the latest scientific developments across the range of antiviral research, emphasizing the interdisciplinary nature of the field. ICAR provides opportunities to develop the collaborative relationships needed for the discovery and development of new antiviral therapies. The conference offers special events to welcome new scientists and help them establish and foster successful careers. ISAR members will strengthen their network of research associates and develop new contacts.
ICAR2026 is organized to foster the interactions and collaborations among researchers in: Academia; Startups; Small, medium and large pharmaceutical companies; Industry; Governmental and nongovernmental organizations; and all others working on the different areas of critical importance for immediate or future antiviral development. What ICAR2026 program format? ICAR2026 will be an in-person meeting! No virtual participation options will be available. The meeting will include oral and poster sessions, plenary talks, ISAR awardee lectures and several special sessions and networking events. All accepted posters will have the option (although highly encouraged) to upload a virtual poster to the online platform which will be available to registered attendees. All poster award competition participants will be required to upload an electronic poster prior to the conference. What are the submission and session tracks?
What are the abstract submission deadlines? The abstract submission site opens November 3, 2025 and the submission deadline is January 9, 2026. If you need an early visa notification, you must submit by December 5, 2025. The poster only submission site will open on January 15, 2026 and close on February 20, 2026. Please continue to check back for program updates. |
ICAR2026 will be held at the Cubex Centrum in Prague, Czech Republic. Cubex is a 